Gabriel Ling - 22 Nov 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Gabriel Ling
Issuer symbol
TOI
Transactions as of
22 Nov 2024
Net transactions value
$0
Form type
4
Filing time
25 Nov 2024, 16:20:39 UTC
Previous filing
28 Dec 2023
Next filing
20 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Award $0 +40,000 +58% $0.000000 109,057 22 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date.